Birch Finance suggests the best credit card for you based off of your spending habits. 2017 saw a lot of new card offerings and deals, but Birch Finance believes the deals are only going to get better in 2018.
Alex Cohen is the CEO of Birch Finance and he joins Cheddar to explain the credit card trends of 2017. The Chase Sapphire Reserve card went viral but also experienced high churn. Uber also launched a credit card that is potentially the best no-fee, cash back card on the market. Cohen believes Lyft might also launch their own credit card to dive into loyalty. He could imagine Air BnB also launching a credit card to expand their offerings.
For 2018, Cohen thinks businesses will launch credit cards that are focused on the millennial shopper. He also anticipates trends toward more co-branded cards and even more competitive premium cards.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
Chris Beauchamp, Chief Market Analyst at IG International, joins J.D. Durkin to give analysis on the recent trade truce between the U.S. and China. Watch!
Shan Aggarwal, VP of Corporate and Business Development at Coinbase, discusses the company's acquisitio of Deribit as it heads into the S&P 500. Watch!
Shopping expert Trae Bodge discusses how talks between the U.S. and China is good news for now, but uncertainty remains for back-to-school and the holidays.
Jake Traylor, White House reporter at Politico, joins Cheddar to discuss how Trump is aiming to lower drug prices and how it differs from Biden's approach.
